期刊文献+

南京及深圳两地女性宫颈HPV感染基因谱的比较研究 被引量:11

A comparative research on gene spectrum of cervical cells in women infected with HPV in Nanjing and Shenzhen regions
暂未订购
导出
摘要 目的比较南京及深圳两地女性宫颈细胞中23种人乳头瘤病毒(HPV)感染的基因型分布情况及其感染的差异性。方法宫颈细胞标本取自南京市扬子石化集团公司的3678例及深圳市妇幼保健院体检的2915例女性,采用基因扩增结合基因芯片技术对6593例宫颈细胞标本进行23种HPV基因型别的检测,并对其结果进行分析。结果 6593例宫颈细胞标本中共检出HPV感染者共1002例,HPV总感染率为15.20%(1002/6593),南京地区总的HPV感染率为10.79%(397/3678),深圳地区总的HPV感染率为20.76%(605/2915);HPV一重感染率南京地区为9.11%(335/3678),深圳地区为15.09%(440/2915);HPV多重感染率南京地区为1.69%(62/3678),深圳地区为5.66%(165/2915)。结论深圳地区HPV总的、一重和多重感染率都明显高于南京地区。 Objective To compare the differences of genotype distribution and infection of 23 kinds of human papillomavirus(HPV) in women cervical cells in Nanjing and Shenzhen regions.Methods Cervical cell samples were obtained from 3 678 women worked in Nanjing Yangzi Petrochemical Corporation and 2 915 women who had undertaken physical examination in Shenzhen Women Child Health Hospital.Genetic amplification combined with gene chips technology was employed to detect genotypes in 23 kinds of HPV in 6 593 samples of cervical cells.Results 1 002 in 6 593 samples of cervical cells were detected to be infected with HPV with overall infection rate of 15.20%(1 002/6 593).The overall HPV infection rate in Nanjing was 10.79%(397/3 678) and 20.76%(605/2 915) in Shenzhen.The single HPV infection rate in Nanjing was 9.11%(335/3 678) and 15.09%(440/2 915) in Shenzhen.The multiple HPV infection rate was 1.69%(62/3 678) and 5.66%(165/2 915) in Shenzhen..Conclusion The overall,single and multiple HPV infection rates in Shenzhen are all markedly higher than those in Nanjing.
出处 《国际检验医学杂志》 CAS 2013年第12期1511-1513,共3页 International Journal of Laboratory Medicine
基金 江苏省南京市卫生局中医专项资助项目(2009-92)
关键词 宫颈 人乳头瘤病毒 基因谱 基因分型 cervical human papillomavirus genetic profile genetyping
  • 相关文献

参考文献14

二级参考文献54

共引文献143

同被引文献103

  • 1杨广宇,徐美华,崔卫东,孙爱华.浙江省杭嘉湖地区妇女宫颈人乳头瘤病毒感染情况分析[J].中华临床感染病杂志,2013,6(4):209-212. 被引量:11
  • 2肖松舒,范洁琳,贺斯黎,于科楠,邓新粮,薛敏.16320例妇科门诊患者HPV感染情况分析[J].中南大学学报(医学版),2015,40(4):373-379. 被引量:26
  • 3潘凌亚.HPV感染与宫颈癌前病变[J].基础医学与临床,2006,26(12):1296-1301. 被引量:26
  • 4Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002 [J]. CA Cancer J Clin, 2005, 55(2): 74-108.
  • 5Forman D, de Martel C, Lacey C], et al. Global burden of human papillomavirus and related diseases [ J ]. Vaccine, 2012, 30 ( Suppl 5) : F12 -F23.
  • 6Munoz N, Bosch FX, de - Sanjose S, et al. Epidemiologic classifi- cation of human papillomavirus types associated with cervical cancer [J]. N Ensl J Med, 2003, 348(6) : 518 -527.
  • 7Wright TC Jr, Huh WK, Monk BJ, et al. Age considerations when vaccinating against HPV[J]. Gynecol Oncol, 2008, 109(2 Suppl) : S40 - S47.
  • 8Munoz N, Bosch FX, Castellsague X, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective[ J]. Int J Cancer, 2004, 11 (2) : 278 - 285.
  • 9Lin H, Ma YY, Moh JS, et al. High prevalence of genital human papillomavirus type 52 and 58 infection in women attending gyneco- logic practitioners in South Taiwan [ J]. Gynecol Oncol 2006, 101 (1):40-45.
  • 10Kay P,Soeters R,Nevin J,et al.High prevalence of HPV 16 in South African women with cancer of the cervix and cervical intraepithelial neoplasia.J Med Virol,2003,71:265-273.

引证文献11

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部